新藥研發產業博士學位學程

Medicine & Life Sciences

1. Taiwan 97%
2. Histone Deacetylase Inhibitors 92%
3. Neoplasms 90%
4. Apoptosis 85%
5. In Vitro Techniques 68%
6. Lipopolysaccharides 66%
7. Proteins 63%
8. Inhibitory Concentration 50 60%
9. Growth 60%
10. Phosphorylation 58%
11. Colorectal Neoplasms 52%
12. Cyclooxygenase 2 49%
13. Cell Line 49%
14. Genes 48%
15. Therapeutics 47%
16. Histone Deacetylases 45%
17. Blood Platelets 44%
18. Cell Movement 42%
19. Anti-Inflammatory Agents 41%
20. Down-Regulation 40%
21. Antioxidants 39%
22. Cell Proliferation 39%
23. Macrophages 37%
24. Gene Expression 36%
25. Mucocutaneous Lymph Node Syndrome 36%
26. Antineoplastic Agents 36%
27. Fibroblasts 34%
28. Inflammation 34%
29. Lung 34%
30. Breast Neoplasms 34%
31. Population 33%
32. Tubulin 33%
33. p38 Mitogen-Activated Protein Kinases 33%
34. Pharmaceutical Preparations 33%
35. Heterografts 32%
36. Nitric Oxide 32%
37. Non-Small Cell Lung Carcinoma 31%
38. Up-Regulation 31%
39. Connective Tissue Growth Factor 29%
40. osthol 29%
41. Lung Neoplasms 29%
42. Phosphotransferases 29%
43. Nitric Oxide Synthase Type II 29%
44. Cell Death 28%
45. Tubulin Modulators 28%
46. Hepatocellular Carcinoma 28%
47. Bone and Bones 28%
48. Protein Kinase C 28%
49. Smooth Muscle Myocytes 28%
50. Matrix Metalloproteinase 9 28%
51. Matrix Metalloproteinases 28%
52. Epithelial Cells 26%
53. Microtubules 26%
54. Extracellular Signal-Regulated MAP Kinases 26%
55. Kidney 26%
56. Oxidative Stress 25%
57. Reactive Oxygen Species 25%
58. Endothelial Cells 25%
59. A549 Cells 25%
60. Caspase 3 25%
61. Cytokines 25%
62. Interleukin-1 25%
63. Magnetic Fields 25%
64. Thrombin 24%
65. Platelet Aggregation 24%
66. Messenger RNA 24%
67. Interleukin-8 23%
68. Glioblastoma 23%
69. Vascular Smooth Muscle 23%
70. Biomarkers 23%
71. Transcription Factor AP-1 23%
72. High Pressure Liquid Chromatography 23%
73. Colonic Neoplasms 22%
74. Peroxisome Proliferator-Activated Receptors 22%
75. Autophagy 22%
76. Human Umbilical Vein Endothelial Cells 22%
77. Nanoparticles 22%
78. Western Blotting 22%
79. Single Nucleotide Polymorphism 21%
80. Cell Cycle Checkpoints 21%
81. Activating Transcription Factor 3 21%
82. Dinoprostone 21%
83. Cohort Studies 20%
84. 2,3,5,4'-tetrahydroxystilbene 2-O-glucopyranoside 20%
85. Cell Cycle 20%
86. denbinobin 20%
87. Dental Pulp 20%
88. Neoplasm Metastasis 20%
89. indoline 20%
90. Xanthine Oxidase 20%
91. Transforming Growth Factors 20%
92. Serum 20%
93. Platelet Activation 20%
94. Stroke 20%
95. Liver 20%
96. Stem Cells 20%
97. Blood Vessels 20%
98. Epithelial-Mesenchymal Transition 19%
99. MicroRNAs 19%
100. Small Interfering RNA 19%

Chemical Compounds

1. Protein 100%
2. Histone 64%
3. Antiproliferative 45%
4. Antineoplastic Agent 39%
5. Drug 36%
6. Antioxidant Agent 34%
7. Antiinflammatory 34%
8. Cell Death 30%
9. Antitumor 30%
10. Lipopolysaccharide 29%
11. Apoptotic 28%
12. Nitric Oxide 28%
13. Growth Factor 24%
14. Marker 24%
15. Genetic Polymorphism 23%
16. 50 Percent Growth Inhibition 23%
17. Plasma 22%
18. Reactive Oxygen Metabolite 22%
19. Application 19%
20. Biological Marker 19%
21. Disorder 18%
22. Acid 18%
23. Oxidative Stress 18%
24. Leaf Like Crystal 18%
25. Dose 18%
26. Hydroxamic Acid 17%
27. Metabolic 17%
28. Metabolite 17%
29. Anticoagulant Agent 16%
30. Cell Viability 16%
31. Flavonoid 16%
32. Protective 16%
33. Resistance 15%
34. Osthole 15%
35. Glucose 15%
36. Collagen 15%
37. Colchicine 14%
38. Hyaluronic Acid 14%
39. Retinal 14%
40. Flow 14%
41. Bioactivity 14%
42. Calcium(0) 14%
43. Antroquinonol 13%
44. High-Pressure Liquid Chromatography 13%
45. Implant 13%
46. Polymerization Reaction 13%
47. Vascular Targeting Agent 13%
48. Andrographolide 12%
49. Neuroprotective 12%
50. Cleavage 12%
51. Weight 12%
52. Aristolochic Acid 12%
53. Pharmacological Metabolism 12%
54. MicroRNA 12%
55. Western Blotting 11%
56. Molecule 11%
57. Chain Reaction 11%
58. Modification 11%
59. Spectroscopic Analysis 10%
60. Acetylation 10%
61. Quercetin 10%
62. Free Radical 10%
63. Bioavailability 10%
64. Trichostatin A 10%
65. Structure-Activity Relationship 10%
66. Growth Inhibition 10%
67. Time 10%
68. Methylglyoxal 10%
69. Membrane Potential 10%
70. Antiacne 10%
71. Poly(ADPribose) 10%
72. Cytometry 10%
73. Nanocarrier 10%
74. Surface 10%
75. Fragmentation 10%
76. 3-Hydroxybutyrate 10%
77. Prostaglandin E2 9%
78. Antiresorptive 9%
79. Fermentation 9%
80. Nanoparticle 9%
81. Cantharidin 9%
82. Hydrogel 9%
83. Amount 9%
84. Glutathione 9%
85. Heme 9%
86. Food 9%
87. Insulin Derivative 9%
88. Hispidulin 9%
89. Lignan 9%
90. Angiogenic 9%
91. Ethanol 9%
92. Tetramethylpyrazine 9%
93. Shikonin 8%
94. Resveratrol 8%
95. Reduction 8%
96. Occurrence in Nature 8%
97. Lipid 8%
98. Estrogen 8%